UBS Group »

Aeon Biopharma I shares owned by UBS Group

Quarter-by-quarter ownership of Aeon Biopharma I (AEON.WS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aeon Biopharma I

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma I held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma I by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $67 890 0.08

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Aeon Biopharma I

Cantor Fitzgerald, L. P.
Davidson Kempner Capital Management
Aristeia Capital
LMR Partners
Tenor Capital Management
D. E. Shaw & Co
Millennium Management
Hudson Bay Capital Management
Whitebox Advisors
Wolverine Asset Management
Kim
Calamos Advisors
Goldman Sachs Group
Sandia Investment Management
Walleye Trading Advisors

View all funds holding Aeon Biopharma I